Cerulean Pharma Inc., of Cambridge, Mass., entered an agreement with Hercules Technology Growth Capital Inc. for a term loan of up to $26 million and a private placement of $1 million of Cerulean common stock in the form of 135,501 unregistered shares at $7.38 apiece.